Travere Therapeutics Reports First Quarter 2023 Financial Results
SAN DIEGO, May 04, 2023 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its first quarter 2023 financial results and provided a corporate update.
View Full Press Release